Lapatinib Completed Phase 2 Trials for Prostate Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00246753Lapatinib in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy